Pharmaceutical Gelatin Market size to Reach USD 1.85 Billion by 2031 Amid Rising Capsule Demand and Biologics Expansion

Introduction   

According to Mordor Intelligence, the pharmaceutical gelatin market size was valued at USD 1.42 billion in 2026 and reach USD 1.85 billion by 2031, registering a CAGR of 5.39% during the forecast period. The pharmaceutical gelatin market size is supported by continued demand for oral solid dosage forms, biologics, vaccines, and specialized drug delivery systems. 

The pharmaceutical gelatin industry remains closely tied to capsule manufacturing, with gelatin widely used in hard and soft capsule shells. Increasing biologics production, vaccine development programs, and expanding nutraceutical consumption are contributing to steady pharmaceutical gelatin market growth. At the same time, sourcing diversification and regulatory compliance are shaping pharmaceutical gelatin market trends across regions. 

Pharmaceutical Gelatin Market Trends Shaping Industry Demand 

Booming Nutraceutical Soft-Gel Demand 

One of the strongest pharmaceutical gelatin market trends is the rapid uptake of soft-gel capsules in nutraceutical and supplement formulations. Omega-3, vitamin D, and other lipid-based supplements require gelatin shells that offer stability, flexibility, and improved bioavailability. Soft-gels continue to gain pharmaceutical gelatin market share due to ease of swallowing and better absorption profiles. 

Growing Use in Biologics and Vaccine Stabilization 

Biologic therapies and advanced vaccines require stabilizing excipients to protect sensitive proteins during freeze-drying and transportation. Collagen-derived gelatin peptides are used to maintain structural integrity in these products. This application area is expanding the pharmaceutical gelatin market size, especially in high-purity and low-endotoxin grades. 

Expansion of Capsule Manufacturing Capacity in Asia 

The pharmaceutical gelatin industry is witnessing increased investment in capsule production facilities across Asia. Contract development and manufacturing organizations are expanding output to serve both domestic generic markets and international pharmaceutical companies. This expansion strengthens regional pharmaceutical gelatin market share and improves supply chain resilience. 

Check out more details and stay updated with the latest industry trends, including the Japanese version for localized insights: https://www.mordorintelligence.com/ja/industry-reports/pharmaceutical-gelatin-market?utm_source=industrytoday  

Pharmaceutical Gelatin Market Segmentation Analysis 

By Source 

• Porcine 
• Bovine 
• Other sources including fish 

By Application 

• Hard capsule manufacturing 
• Soft capsule manufacturing 
• Tablet coating and binding 
• Vaccine stabilizers and other pharmaceutical uses 

By Type 

• Type A 
• Type B 
• Other modified grades 

By Geography 

• North America 
• Europe 
• Asia Pacific 
• Middle East and Africa 
• South America 

Explore Our Full Library of Healthcare Research Report:  https://www.mordorintelligence.com/market-analysis/healthcare?utm_source=industrytoday    

Pharmaceutical Gelatin Market Competitive Landscape and Key Players 

The pharmaceutical gelatin market remains moderately fragmented, with several multinational and regional companies competing across product grades and geographies. Competitive positioning within the pharmaceutical gelatin industry depends on raw material sourcing, purification technologies, regulatory compliance, and geographic footprint. 

Key players in the pharmaceutical gelatin market include: 

• Gelita AG 
• Weishardt 
• Darling Ingredients Inc. 
• Tessenderlo Group (PB Leiner) 
• NITTA GELATIN, INC 

Explore more insights on pharmaceutical gelatin competitive landscape: https://www.mordorintelligence.com/industry-reports/pharmaceutical-gelatin-market/companies?utm_source=industrytoday  

Conclusion 

The pharmaceutical gelatin market is positioned for consistent expansion through the forecast period. With projected growth from USD 1.35 billion in 2025 to USD 1.85 billion by 2031, the pharmaceutical gelatin market size reflects sustained reliance on gelatin in capsule manufacturing, biologics stabilization, and specialized formulations. 

While supply chain volatility and regulatory shifts toward alternative capsule materials may influence certain segments, the pharmaceutical gelatin industry continues to benefit from established applications and expanding healthcare demand. Soft-gel technologies, biologic therapies, and diversification into fish-based sources are shaping pharmaceutical gelatin market trends globally. 

Get detailed insights on the pharmaceutical gelatin market: https://www.mordorintelligence.com/industry-reports/pharmaceutical-gelatin-market?utm_source=industrytoday    

Industry Related Reports 

Gel Documentation Systems Market: https://www.mordorintelligence.com/industry-reports/gel-documentation-systems-market?utm_source=industrytoday 

Serum Separation Gel Market Size: https://www.mordorintelligence.com/industry-reports/serum-separation-gel-market?utm_source=industrytoday 

Softgel Capsules Market Share: https://www.mordorintelligence.com/industry-reports/softgel-capsules-market?utm_source=industrytoday 

About Mordor Intelligence: 

Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals. 

For any inquiries or to access the full report, please contact: 

media@mordorintelligence.com 

https://www.mordorintelligence.com/